Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 7, 2015, Pages 693-700

  Ehrenstein, Vera ^a   Gammelager, Henrik ^a   Schiødt, Morten ^b   Nørholt, Sven Erik ^a   Neumann Jensen, Bjarne ^c   Folkmar, Troels Bille ^a   Pedersen, Lars ^a   Sværke, Claus ^a   Sørensen, Henrik Toft ^a   Ma, Haijun ^d   Acquavella, John ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AMGEN INC   (United States)

Author keywords

Administrative data; Cancer; Denmark; International classification of diseases; Osteonecrosis of the jaw; Pharmacoepidemiology; Validation

Indexed keywords

IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGED; ANTIANGIOGENIC THERAPY; ANTIBIOTIC THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLASSIFICATION ALGORITHM; CLINICAL PRACTICE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DRUG SURVEILLANCE PROGRAM; EVALUATION STUDY; FEMALE; HUMAN; HUMAN TISSUE; ICD-10; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; PAIN SEVERITY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TOOTH EXTRACTION; ALGORITHM; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; DENMARK; ELECTRONIC MEDICAL RECORD; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; NEOPLASMS; PHARMACOEPIDEMIOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA;

AGED; ALGORITHMS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DENMARK; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PHARMACOEPIDEMIOLOGY; REGISTRIES;

EID: 84933677141     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3786     Document Type: Article

References (33)

1. Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann N Y Acad Sci 2011; 28.
2. Thumbigere-Math V, Tu L, Huckabay S, et al. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates. Am J Clin Oncol 2012; 35(4): 386-92.
3. Qi WX, Tang LN, He AN, Yao Y, Shen Z. Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol 2014; 19(2): 403-10.
4. Henry DH, Costa L, Goldwasser F, et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 2011; 29(9): 1125-32.
5. Stopeck AT, Lipton A, Body JJ, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 2010; 28(35): 5132-9.
6. Bagan J, Scully C, Sabater V, Jimenez Y. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update. Oral Oncol 2009; 45(7): 551-4.
7. Baillargeon J, Kuo YF, Lin YL, Wilkinson GS, Goodwin JS. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates. Ann Pharmacother 2011; 45(10): 1199-206.
8. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23(34): 8580-7.
9. Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009; 67(5): 2-12.
10. Vestergaard P, Schwartz K, Rejnmark L, Mosekilde L, Pinholt EM. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. J Oral Maxillofac Surg 2012; 70(4): 821-9.
11. Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int 2013; 24(1): 237-44.
12. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22(10): 1479-91.
13. Mauri D, Valachis A, Polyzos IP, Polyzos NP, Kamposioras K, Pesce LL. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast Cancer Res Treat 2009; 116(3): 433-9.
14. Grbic JT, Black DM, Lyles KW, et al. The incidence of osteonecrosis of the jaw in patients receiving 5milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc 2010; 141(11): 1365-70.
15. Guarneri V, Miles D, Robert N, et al. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat 2010; 122(1): 181-8.
16. Ruggiero SL, Dodson TB. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaws-2014 update. J Oral Maxillofac Surg 2014; 72(12): 2381-2.
17. Tennis P, Rothman KJ, Bohn RL, et al. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf 2012; 21(8): 810-7.
18. Schiodt M, Reibel J, Oturai P, Kofod T. Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117(2): 204-13.
19. Arrain Y, Masud T. A current update on osteonecrosis of the jaw and bisphosphonates. Dent Update 2011; 38(10): 672-6.
20. Saad F, Brown JE, Van Poznak C, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 2012; 23(5): 1341-7.
21. Gammelager H, Erichsen R, Antonsen S, et al. Positive predictive value of the International Classification of Diseases, 10th revision, codes to identify osteonecrosis of the jaw in patients with cancer. Cancer Epidemiol 2012; 36(4): 381-3.
22. Gammelager H, Svaerke C, Noerholt SE, et al. Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients. Clin Epidemiol 2013; 5: 263-7.
23. SKS-browser, vers 4.02. Available at: http://www.medinfo.dk/sks/brows.php [15 December 2014].
24. Bergdahl J, Jarnbring F, Ehrenstein V, et al. Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register. Clinical epidemiology 2013; 5: 1-7.
25. Tennis P, Zavras A, Laskarides C, Tan H. Predictive value of ICD and CPT codes for identifying osteonecrosis of the jaw (ONJ). Abstract presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Pharmacoepidemiol Drug Saf 2009; 18(1): S153-S154.
26. Epidemiology FL. When an entire country is a cohort. Science 2000; 287(5462): 2398-9.
27. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39(7): 30-6.
28. The Danish regions in brief. Available at: http://www.regioner.dk/In%20English/Publications%20and%20Policy%20Papers/The%20Regions%20in%20Denmark.aspx [3 May 2010].
29. Statistics Denmark. Population and population projections. Available at: http://statistikbanken.dk/statbank5a/default.asp?w=1920 [1 June 2014].
30. Gammelager H, Christiansen CF, Johansen MB, Borre M, Schoonen M, Sorensen HT. Quality of urological cancer diagnoses in the Danish National Registry of Patients. Eur J Cancer Prev 2012; 21(6): 545-51.
31. Helqvist L, Erichsen R, Gammelager H, Johansen MB, Sorensen HT. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. Eur J Cancer Care 2012; 21(6): 722-7.
32. Tetsche MS, Norgaard M, Skriver MV, Andersen ES, Lash TL, Sorensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol 2005; 26(3): 266-70.
33. Schiødt M, Wexell CL, Herlofson BB, Giltvedt KM, Nørholt SE, Ehrenstein V. Existing data sources for clinical epidemiology: Scandinavian cohort for osteonecrosis of the jaw-work in progress and challenges. Clin Epidemiol 2015; 7: 107-16.